AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2025
May 8, 2025
32407_dirs_2025-05-08_0579fed9-6850-4a3e-a777-e25c0a790a15.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2025-05-06
Reporting Person: Parikh Asit (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-06 | Common Stock | P | 5000 | $2.6 | Acquired | 90500 | Direct |
| 2025-05-07 | Common Stock | P | 5000 | $2.3969 | Acquired | 95500 | Direct |
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12